Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award

Reina Sofia University Hospital/IMIBIC - Spain

Author Profile

Early academic pursuits 🎓

Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.

Professional endeavors 👨‍🌾

Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.

Contributions and research focus 🔧

Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.

Accolades and recognition 🌟

Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.

Impact and influence 🌍

Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.

Legacy and future contributions 🔄

Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..

Notable publications

Title: Invasive aspergillosis in liver transplant recipients in the current era
Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107
Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
Journal: Antibiotics, 2024, 13(9), 792
Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141
Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385
Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230

🌱 Early academic pursuits

Dr. Subash Chandra Sonkar's academic journey began with a b.sc. in chemistry, botany, and zoology from v.b.s. purvanchal university, jounpur, uttar pradesh. his passion for science deepened as he pursued an m.sc. in applied microbiology at banaras hindu university, where he conducted research under the mentorship of prof. arti kapil at aiims, new delhi. dr. sonkar's academic career culminated with a ph.d. in biomedical science from the university of delhi, under the guidance of prof. daman saluja, focusing on designing naat-based diagnostic assays for trichomonas vaginalis detection.

🔬 Professional endeavors

Dr. Sonkar's professional journey has been marked by a series of impactful roles. he has served as a research scientist-ii at the multidisciplinary research unit of maulana azad medical college, contributing to important medical research projects. his experience extends to advisory positions, including his role as a technical advisor for the indian council of medical research (icmr), where he contributed to national mental health capacity building programs.

💡 Contributions and research focus

Dr. Sonkar’s contributions to public health and biomedical science are vast, particularly in the areas of diagnostics and viral infections. he has led research on the role of viral infections in adverse birth outcomes and the development of point-of-care diagnostic devices, including rt-lamp and lfa-based assays for sars-cov-2. his Medical Science postdoctoral research also includes designing multiplex diagnostic kits for detecting sexually transmitted infections.

🏆 Accolades and recognition

Throughout his career, dr. sonkar has garnered recognition for his pioneering research and innovation. he has been a postdoctoral fellow at prestigious institutions like the public health research institute of india and vardhmaan mahaveer medical college. his work in diagnostic assays and medical devices has earned him Medical Science international acclaim, particularly in public health and biomedical sciences.

🌍 Impact and influence

Dr. Sonkar’s research has had a far-reaching impact on public health, particularly in india. his work on diagnostics for viral infections and sexually transmitted diseases has improved early detection and contributed to better healthcare outcomes. his role in the development of diagnostic kits during the covid-19 pandemic Medical Science highlights his significant contributions to global health.

🔗 Legacy and future contributions

Dr. Sonkar’s legacy lies in his multidisciplinary approach to biomedical research. his expertise in diagnostics, public health, and medical device development positions him as a leader in healthcare innovation. his future contributions are expected to further advance diagnostics and public health, ensuring better healthcare access and outcomes worldwide.

Notable Publications

Title: Insights into the Emergence and Evolution of Monkeypox Virus: Historical Perspectives, Epidemiology, Genetic Diversity, Transmission, and Preventative Measures
Authors: Krishna, S., Kurrey, C., Yadav, M., Chandra, L., Koner, B.C.
Journal: Infectious Medicine, 2024, 3(2), 100105

Title: Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Authors: Sakthivel, S., Srivastava, M., Barman, M.K., Sonkar, S.C., Bhukya, P.
Journal: Research Anthology on Bioinformatics, Genomics, and Computational Biology, 2024, pp. 428–456

Title: Molecular Farming and Anticancer Vaccine: Current Opportunities and Openings
Authors: Ratre, Y.K., Mehta, A., Shinde, S., Shukla, D., Vishvakarma, N.K.
Journal: Microbial Bioreactors for Industrial Molecules, 2023, pp. 355–373

Title: Preface
Authors: Bhukya, P.L., Mhaske, S.T., Sonkar, S.C.
Journal: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever, 2023, 1, pp. ix

Title: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever
Authors: Bhukya, P.L., Mhaske, S.T., Sonkar, S.C.
Journal: Emerging Human Viral Diseases, Volume I: Respiratory and Haemorrhagic Fever, 2023, 1, pp. 1–587